SCM
XFOR icon

Sterling Capital Management’s X4 Pharmaceuticals XFOR Stock Holding History

Sterling Capital Management’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.61K Buy
+1,629
New +$6.68K ﹤0.01% 2379
2025
Q2 		– Sell
-6
Closed -$41 – 3412
2025
Q1 		$41 Hold
6
– – ﹤0.01% 3184
2024
Q4 		$126 Hold
6
– – ﹤0.01% 3162
2024
Q3 		$115 Buy
+6
New +$125 ﹤0.01% 3179

Other funds holding XFOR

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sterling Capital Management's XFOR Position: Q2 2026 in Review

Sterling Capital Management opened a new position in X4 Pharmaceuticals (XFOR) in Q2 2026: 1,629 shares worth $7.61K. The stake represents ﹤0.01% of the portfolio and ranks #2379 among its holdings. This is a return to the name: Sterling Capital Management previously reported a position in XFOR as recently as Q1 2025.

Sterling Capital Management first reported a position in XFOR in Q3 2024 and has held it in 4 quarters since. 89 funds tracked by Wall St. Rank hold XFOR as of Q2 2026.

  • Sterling Capital Management held 1,629 shares of X4 Pharmaceuticals worth $7.61K as of Q2 2026.
  • X4 Pharmaceuticals was a new Sterling Capital Management position in Q2 2026.
  • X4 Pharmaceuticals made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2379 holding.
  • Sterling Capital Management first reported a position in X4 Pharmaceuticals in Q3 2024 and has held it in 4 quarters since.
  • 89 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.